TITLE

Lipoprotein-Associated Phospholipase A2 and Risk Stratification for Cardiovascular Disease: Not Ready for "Prime Time"

AUTHOR(S)
Steinberg, Daniel I.; Alexander Mayer
PUB. DATE
February 2007
SOURCE
Mayo Clinic Proceedings;Feb2007, Vol. 82 Issue 2, p155
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on cardiovascular disease (CVD) and lipoprotein-associated phospholipase A2 (Lp-PLA2) in the U.S. Cardiovascular disease was the contributing cause of death in 58% of all American deaths in 2003. Research has focused on whether markers of inflammation can aid the prediction of CVD. The role of Lp-PLA2 is still unclear.
ACCESSION #
24013409

 

Related Articles

  • Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2 ): a review.  // Lipids in Health & Disease;2011, Vol. 10 Issue 1, p170 

    The article cites a research study that examines the lipoprotein-associated phospholipase A2 (Lp-PLA2), and its antioxidant and inflammatory aspects. It is said that Lp-PLA2 is associated with several cardiovascular risk markers and events. The evaluation of the distribution of the enzyme in the...

  • The relationship between Lp-PLA2 level and severity coronary artery disease in patient with acute coronary syndrome. Gunay, Tufan; Demir, Mehmet; Orhan, Ahmet Lutfu; Eren, Mehmet // HealthMed;2012, Vol. 6 Issue 12, p4106 

    Background: Inflammation is one of the factors playing role in acute coronary syndrome (ACS). Many independent evaluation studies have been published verifying the role of inflammation in atherogenesis and supporting the opinion that lipoprotein-associated phospholipase A2 (Lp-PLA2) is a...

  • Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2). Tselepis, Alexandros D.; Rizzo, Manfredi; Goudevenos, Ioannis A. // Current Pharmaceutical Design;11/11/2011, Vol. 17 Issue 33, p3656 

    Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a calcium-independent phospholipase A2 that circulates in plasma in association with lipoprotein particles, whereas in atherosclerotic plaques it is co-localized with macrophages. Lp-PLA2 generates two proinflammatory mediators,...

  • Phosphatidylethanol Stimulates Calcium-Dependent Cytosolic Phospholipase A[sub 2] Activity of a Macrophage Cell Line (RAW 264.7). Chang, Chia-Yu; Farrell, Kathryn R.; Baker, Rodney C. // Journal of Biomedical Science;2000, Vol. 7 Issue 4, p311 

    The synthesis of inflammation mediators produced from arachidonic acid is regulated primarily by the cellular concentration of free arachidonic acid. Since intracellular arachidonic acid is almost totally present as phospholipid esters, the concentration of intracellular arachidonic acid is...

  • Characterization of Group X Phospholipase A2 as the Major Enzyme Secreted by Human Keratinocytes and its Regulation by the Phorbol Ester TPA. Schadow, Alexia; Scholz-Pedretti, Kirsten; Lambeau, Gérard; Gelb, Michael H.; Fürstenberger, Gerhard; Pfeilschifter, Josef; Kaszkin, Marietta // Journal of Investigative Dermatology;Jan2001, Vol. 116 Issue 1, p31 

    SummaryHaCaT as well as human primary keratinocytes constitutively expressed mRNA of the human secreted phospholipase A2 subtype groups X, V, IIA, and IID. A similar expression pattern was also found in human skin biopsies. Protein analysis showed that under serum-free conditions only group X...

  • Genome-Wide Association Study of Lp-PLA2 Activity and Mass in the Framingham Heart Study. Suchindran, Sunil; Rivedal, David; Guyton, John R.; Milledge, Tom; Xiaoyi Gao; Benjamin, Ashlee; Rowell, Jennifer; Ginsburg, Geoffrey S.; McCarthy, Jeanette J. // PLoS Genetics;Apr2010, Vol. 6 Issue 4, p1 

    Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an emerging risk factor and therapeutic target for cardiovascular disease. The activity and mass of this enzyme are heritable traits, but major genetic determinants have not been explored in a systematic, genome-wide fashion. We carried out a...

  • Cellular and Molecular Bases of the Initiation of Fever. Steiner, Alexandre A.; Ivanov, Andrei I.; Serrats, Jordi; Hosokawa, Hiroshi; Phayre, Allison N.; Robbins, Jared R.; Roberts, Jennifer L.; Kobayashi, Shigeo; Matsumura, Kiyoshi; Sawchenko, Paul E.; Romanovsky, Andrej A. // PLoS Biology;Sep2006, Vol. 4 Issue 9, p1517 

    All phases of lipopolysaccharide (LPS)-induced fever are mediated by prostaglandin (PG) E2. It is known that the second febrile phase (which starts at ;1.5 h post-LPS) and subsequent phases are mediated by PGE2 that originated in endotheliocytes and perivascular cells of the brain. However, the...

  • The inflammatory cancer hypothesis. Fredericks, E. // South African Gastroenterology Review;Apr2014, Vol. 12 Issue 1, p19 

    The article focuses on the relationship between inflammation and cancer. It states the role of prostaglandins in inflammation and mentions the two classes of the enzyme phospholipase A2 (PLA2) including the calcium-independent intracellular PLA2 and the calcium-dependent PLA2. It further...

  • 3D QSAR Study of Human PLA2 Inhibitors. A Modeling Approach to Select New and Specific Anti-Inflammatory Drugs. Pintore, Marco; Mombelli, Enrico; Wechman, Christophe; Chretien, Jacques R. // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;May2006, Vol. 5 Issue 2, p175 

    High concentrations of human non pancreatic secretory phospholipase A2 (hnps-PLA2) have been reported as inducing factors in different inflammatory diseases. Thus, hnps-PLA2 inhibitors would be potential drugs against disorders generated by high levels of this enzyme. The latter has been...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics